secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017744
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity faces Nasdaq delisting for missing annual meeting; closes $354k private placement
--------------------------------------------------------------------------------

- Nasdaq notified Biotricity on May 1, 2024 of non-compliance with annual meeting rule; additional delisting basis.
- Company must respond to Nasdaq Hearings Panel by May 8, 2024; intends to hold meeting as soon as practicable.
- On April 30, 2024, closed second tranche of private placement: 39 Series B Preferred shares for $354,545.
- Registration Rights Agreement filed; failure to file or obtain effectiveness triggers 100,000 common shares per event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224017744/0001493152-24-017744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224017744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer